Heterogeneity of financial toxicity and associated risk factors for older cancer survivors in China
- PMID: 37731611
- PMCID: PMC10507189
- DOI: 10.1016/j.isci.2023.107768
Heterogeneity of financial toxicity and associated risk factors for older cancer survivors in China
Abstract
In China, older cancer survivors may show heterogeneity in financial toxicity (FT). We aimed to identify FT profiles among older Chinese cancer survivors and examine the association between FT profiles and individual characteristics. We used a latent profile analysis to categorize participants and a multinomial logistic regression to examine the associations. We identified three distinct FT profiles: high, moderate, and low. Participants aged 65-69 years, with a monthly household income ≥ 5,000 CNY and a high school education or above were more likely to be classified into the moderate than high FT profile, a monthly household income ≥ 5,000 CNY increased the likelihood of being in the low FT profile and living alone negatively affected the odds of being in the low FT profile. The findings identified heterogeneity in FT among this population, may help identify high-risk groups, and may enable early intervention.
Keywords: Cancer; Patient social context; Public health; Socioeconomic status.
© 2023 The Authors.
Conflict of interest statement
There are no competing interests to declare.
Figures
Similar articles
-
Potential profile analysis of financial toxicity and its related factors among lung cancer patients.BMC Cancer. 2025 Apr 21;25(1):740. doi: 10.1186/s12885-025-14076-1. BMC Cancer. 2025. PMID: 40259218 Free PMC article.
-
Explore Potential Profiles and Influencing Factors for Financial Toxicity in Patients with Colorectal Cancer Undergoing Chemotherapy: A Cross-Sectional Study.Semin Oncol Nurs. 2025 Feb;41(1):151762. doi: 10.1016/j.soncn.2024.151762. Epub 2024 Dec 13. Semin Oncol Nurs. 2025. PMID: 39674790
-
Profiles of financial toxicity and influencing factors among cancer patients: A latent profile analysis.Res Social Adm Pharm. 2024 Feb;20(2):137-144. doi: 10.1016/j.sapharm.2023.10.010. Epub 2023 Nov 4. Res Social Adm Pharm. 2024. PMID: 37949721
-
Relationships Between Financial Toxicity and Symptom Burden in Cancer Survivors: A Systematic Review.J Pain Symptom Manage. 2019 Mar;57(3):646-660.e1. doi: 10.1016/j.jpainsymman.2018.12.003. Epub 2018 Dec 12. J Pain Symptom Manage. 2019. PMID: 30550833
-
Prevalence and risk factors of self-reported financial toxicity in cancer survivors: A systematic review and meta-analyses.J Psychosoc Oncol. 2023;41(4):457-474. doi: 10.1080/07347332.2022.2142877. Epub 2022 Nov 12. J Psychosoc Oncol. 2023. PMID: 36370039
Cited by
-
Disparities in cancer-related financial toxicity across economically diverse provinces in China: A multi-center cross-sectional study.Asia Pac J Oncol Nurs. 2024 Dec 9;12:100636. doi: 10.1016/j.apjon.2024.100636. eCollection 2025 Dec. Asia Pac J Oncol Nurs. 2024. PMID: 39839728 Free PMC article.
-
Financial toxicity and quality of life among older adults with cancer: a moderated mediation model of loneliness and social support.Support Care Cancer. 2025 Jul 11;33(8):680. doi: 10.1007/s00520-025-09718-w. Support Care Cancer. 2025. PMID: 40640458
-
Financial toxicity and its risk factors among patients with cancer in China: A nationwide multisite study.Asia Pac J Oncol Nurs. 2024 Mar 15;11(5):100443. doi: 10.1016/j.apjon.2024.100443. eCollection 2024 May. Asia Pac J Oncol Nurs. 2024. PMID: 38665637 Free PMC article.
-
Influence of age on financial toxicity in cancer patients.Asia Pac J Oncol Nurs. 2024 Jul 5;11(9):100552. doi: 10.1016/j.apjon.2024.100552. eCollection 2024 Sep. Asia Pac J Oncol Nurs. 2024. PMID: 39220148 Free PMC article.
-
Potential profile analysis of financial toxicity and its related factors among lung cancer patients.BMC Cancer. 2025 Apr 21;25(1):740. doi: 10.1186/s12885-025-14076-1. BMC Cancer. 2025. PMID: 40259218 Free PMC article.
References
-
- IQVIA Global Oncology Trends 2022. 2021. https://www.iqvia.com/insights/the-iqvia-institute/reports/global-oncolo...
-
- de Souza J.A., Yap B.J., Wroblewski K., Blinder V., Araújo F.S., Hlubocky F.J., Nicholas L.H., O'Connor J.M., Brockstein B., Ratain M.J., et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) Cancer. 2017;123:476–484. doi: 10.1002/cncr.30369. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources